North American Morning Briefing: Tariff Jitters -2-
Reliv International Inc (RELV) is expected to report for 4Q. Rubicon Technology Inc (RBCN) is expected to report for 4Q. Ryvyl Inc (RVYL) is expected to report $-0.33 for 4Q. SouthGobi Resources Ltd ...
Yahoo Finance2d
United Therapeutics Corporation (UTHR)
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that ...
What is Stifel Canada’s Forecast for TSE:HLS Q1 Earnings?
Equities researchers at Stifel Canada issued their Q1 2025 earnings per share (EPS) estimates for shares of HLS Therapeutics ...
United Therapeutics: Don't Fear The Patent Expiration Too Much
United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings
Cintas Corporation CTAS shares jumped over 8% on Wednesday after the company posted better-than-expected third-quarter ...
ETF Daily News6d
Analysts Set Summit Therapeutics Inc. (NASDAQ:SMMT) Target Price at $34.11
Shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten analysts that are presently covering the stock ...
Aardvark Therapeutics price target raised to $26 from $22 at BofA
BofA analyst Tim Anderson raised the firm’s price target on Aardvark Therapeutics (AARD) to $26 from $22 and keeps a Buy rating on the shares ...
Investing2d
Prelude Therapeutics stock surges on insider buying
Investing.com -- Shares of Prelude Therapeutics Inc (NASDAQ:PRLD) climbed 13% in after-hours trading following news that insiders, including CEO Vaddi Krishna and Chief Chemistry Officer Andrew ...
Seeking Alpha1d
UTHR United Therapeutics Corporation
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...
North American Morning Briefing: Stock Futures -2-
Maravai LifeSciences Holdings Inc (MRVI) is expected to report $-0.07 for 4Q. McCormick & Co Inc (MKC) is expected to report $0.64 for 1Q. Movado Group Inc (MOV) is expected to report $0.39 for 4Q.
Investing4d
Cathie Wood’s ARK focuses on Beam Therapeutics, Intuitive Machines stock
Cathie Wood’s ARK ETFs have published their daily trades for Tuesday, March 25th, 2025, revealing a series of strategic moves in the biotech and tech sectors. Leading the pack in dollar value ...
Taiwan News3d
Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
SAN JOSE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral ...